Dysregulation of Cationic Channels in Chronic Kidney Diseases

dc.contributor.advisorDryer, Stuart E.
dc.contributor.committeeMemberRoman, Gregg
dc.contributor.committeeMemberDauwalder, Brigitte
dc.contributor.committeeMemberEriksen, Jason
dc.contributor.committeeMemberWang, Yanlin
dc.creatorRoshanravan, Hila 1985-
dc.date.accessioned2018-07-13T21:37:34Z
dc.date.available2018-07-13T21:37:34Z
dc.date.createdMay 2016
dc.date.issued2016-05
dc.date.submittedMay 2016
dc.date.updated2018-07-13T21:37:34Z
dc.description.abstractAccording to the Centers for Disease Control and Prevention, one in 10 American adults, has some level of chronic kidney disease (CKD), a condition characterized by reduced kidney function over time. Although recent research has uncovered many pathways and mechanisms involved in the pathophysiology of kidney diseases, this has not yet led to development of new drugs for the treatment of patients with these conditions. In this dissertation, we introduce two potential therapeutic targets for different forms of CKD. First, we discuss gating properties of the transient receptor potential cationic-6 (TRPC6) channel, then we show dysregulation of this channel in models of focal segmental glomerulosclerosis (FSGS). In a separate chapter, we introduce another channel protein, the N-methyl-D-aspartate (NMDA) receptor, as a potential therapeutic target for treatment of diabetic nephropathy. Much of this work entailed making whole-cell recordings from highly specialized kidney cells called podocytes. This technique was used to measure TRPC6 channel activity in cells in vitro, as well as in ex vivo preparations in which podocytes are still attached to the isolated glomerular capillary. Serum samples from a variety of primary FSGS patient groups were obtained from collaborators. We used the sera to treat our cells in vitro and investigate the effect of soluble factors in the patients’ serum on the activity and expression levels of TRPC6 channels. Regarding the other target, we studied the effect of NMDA inhibitors in alleviating the development of diabetic nephropathy in vivo. I concluded that TRPC6 channels are dysregulated in FSGS. This suggested that further development of TRPC6 inhibitors might be warranted as potential therapeutic agents. We observed that diabetes caused a marked increase in the expression of renal NMDA receptors, and that sustained treatment with NMDA antagonists reduces the progression of nephropathy in two mouse models of type-1 diabetes. Consequently, it is possible that this class of drugs can be useful for reducing the progression of nephropathy.
dc.description.departmentBiology and Biochemistry, Department of
dc.format.digitalOriginborn digital
dc.format.mimetypeapplication/pdf
dc.identifier.citationPortions of this document appear in: Roshanravan, Hila, and Stuart E. Dryer. "ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species." American Journal of Physiology-Renal Physiology 306, no. 9 (2014): F1088-F1097. https://doi.org/10.1152/ajprenal.00661.2013.
dc.identifier.urihttp://hdl.handle.net/10657/3266
dc.language.isoeng
dc.rightsThe author of this work is the copyright owner. UH Libraries and the Texas Digital Library have their permission to store and provide access to this work. UH Libraries has secured permission to reproduce any and all previously published materials contained in the work. Further transmission, reproduction, or presentation of this work is prohibited except with permission of the author(s).
dc.subjectChronic kidney diseases
dc.subjectIon channels
dc.subjectDiabetic nephropathy
dc.subjectFocal segmental glomerulosclerosis (FSGS)
dc.subjectTRPC6
dc.subjectN-methyl-D-aspartate (NMDA)
dc.titleDysregulation of Cationic Channels in Chronic Kidney Diseases
dc.type.dcmiText
dc.type.genreThesis
thesis.degree.collegeCollege of Natural Sciences and Mathematics
thesis.degree.departmentBiology and Biochemistry, Department of
thesis.degree.disciplineCell and Molecular Biology
thesis.degree.grantorUniversity of Houston
thesis.degree.levelDoctoral
thesis.degree.nameDoctor of Philosophy

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ROSHANRAVAN-DISSERTATION-2016.pdf
Size:
3.69 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
1.82 KB
Format:
Plain Text
Description: